We present a clinical case of de novo AML with concurrent BCR‐ABL1 and CBFB‐MYH11 rearrangements and discuss the diagnostic challenges, treatment implications, and prognostic implications. The gene discussed is BCR; the disease is acute myeloid leukemia.